Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
about
Cost-effectiveness of alternative strategies for provision of HIV pre-exposure prophylaxis for people who inject drugs.Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand
P2860
Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Estimation of the cost-effecti ...... tates: A model-based analysis.
@ast
Estimation of the cost-effecti ...... tates: A model-based analysis.
@en
type
label
Estimation of the cost-effecti ...... tates: A model-based analysis.
@ast
Estimation of the cost-effecti ...... tates: A model-based analysis.
@en
prefLabel
Estimation of the cost-effecti ...... tates: A model-based analysis.
@ast
Estimation of the cost-effecti ...... tates: A model-based analysis.
@en
P2093
P2860
P1433
P1476
Estimation of the cost-effecti ...... tates: A model-based analysis.
@en
P2093
Cora L Bernard
Douglas K Owens
Margaret L Brandeau
P2860
P304
P356
10.1371/JOURNAL.PMED.1002312
P407
P577
2017-05-24T00:00:00Z